VivoSeq
Other

Pediatrics

0

Pipeline Programs

3

Active Trials

5

Companies Involved

Pediatrics is an early-stage landscape with 0 programs across 5 companies. The most active players are GSK, AstraZeneca, Bayer.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

94/100

Attrition Rate

5/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

22

clinical trials

Completed16 · 73%
Recruiting3 · 14%
Unknown status2 · 9%
Withdrawn1 · 5%

Trial Activity

22 trials

Qvar vs FP in Pediatrics
Completed·RResearch in Real-Life Ltd·N/A·NCT01877954·2,654 enrolled
Afrezza® INHALE-1 Study in Pediatrics
Completed·MMannkind Corporation·Phase 3·NCT04974528·319 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)